在GDF5的复杂调节相互作用塑造了关节形态和骨关节炎疾病风险
Clarissa R Coveney1,2, David Maridas3, Hao Chen4
1Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA.
Arthritis & rheumatology (Hoboken, N.J.)
|May 13, 2025
概括
研究GDF5的基因调节揭示了影响骨关节炎 (OA) 风险的复杂相互作用. 个体变异可能不是因果关系,突出显示了局部表皮病在OA疾病生物学中的作用.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 类风湿病学 类风湿病学
背景情况:
- 骨关节炎 (OA) 是一种复杂的疾病,具有重要的遗传成分.
- GDF5位点是理解OA病变的关键领域.
- 调控因素在基因表达和疾病发展中起着至关重要的作用.
研究的目的:
- 通过检查GDF5基因的调节相互作用来研究OA的因果机制.
- 确定特定GDF5调节区域对基因表达和关节形态的功能影响.
- 在增强剂中建模OA风险变异,以评估它们对基因表达和疾病结果的影响.
主要方法:
- 对GDF5调节区域 (R2,R3-5,R7-R9,R18-20,GROW1) 的分析,以检测体外和体内的功能影响.
- 在体外和体外小鼠模型中研究增强剂中的OA变体.
- 评估基因表达,关节形态和与目标监管区域和变异相关的OA风险.
主要成果:
- 在GDF5内的调节区域表现出复杂的激活/抑制模式,影响关节特异性表达.
- R4增强剂具有双重作用,抑制邻近组织中的表达.
- 针对R2de区域减少了Gdf5表达,改变了关节形态,但没有增加OA风险.
- 一种常见的骨关节炎风险变体 (rs143384) 没有直接影响,但与其他变体的表达受到了表达的影响.
结论:
- 基因调节相互作用和局部表观症是OA病因学的关键因素.
- 这项研究提供了对GDF5位点OA复杂遗传结构的见解.
- 高意义的GWAS变异不应仅仅被认为是OA的原因,没有进一步的功能性调查.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Bone Formation by Endochondral Ossification
3.6K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
3.6K
Development of the Limb Synovial Joints
1.3K
Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
1.3K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K


